Current Affairs
Daily Bits

RLF-100 or Aviptadil

  • Posted By
    10Pointer
  • Categories
    Science & Technology
  • Published
    18th Aug, 2020
  • RLF-100 is being probed to treat Covid-19 patients as initial studies have shown that the drug is able to halt SARS-CoV-2 virus replication in lungs.
  • RLF-100 or Aviptadil is a formulation of synthetic human Vasoactive Intestinal Polypeptide (VIP).
  • VIP is released throughout the body, but remains mostly concentrated in lungs.
  • It is produced by immune cells and nerve endings and acts as a neurotransmitter.
  • It helps improve muscle activity and blood flow in gastrointestinal tract.
  • VIP has anti-inflammatory and anti-cytokine activity properties.
  • It protects alveolar type II cells responsible for oxygen exchange in lungs.
  • Since coronavirus attacks lungs and the alveolar cells, drug may be helpful in preventing SARS-CoV-2 onslaught in alveolar cell and limit damage in lung.

Verifying, please be patient.

X